SCHEMBL6983845

SCHEMBL6983845

CC1Cc2cc([N+](=O)[O-])ccc2N(C(=O)CCc2ccc(C#N)cc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.45
KCNH2 Q12809 2/20 0.45
DRD4 P21917 1/20 0.41
ALDH1A1 P00352 7/20 0.41
GAA P10253 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
FFAR1 O14842 1/20 0.41
MAPT P10636 5/20 0.40
LMNA P02545 4/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC6A9 P48067 1/20 0.40
SLC6A5 Q9Y345 1/20 0.40
HTT P42858 1/20 0.39
ABCB1 P08183 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
KDM4E B2RXH2 2/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6974883 0.85 TP53 (0.41) ALDH1A1SMN1; SMN2FFAR1MAPTMAPK1
SCHEMBL6984975 0.84 DRD4 (0.57) KCNJ1KCNH2DRD4ALDH1A1GAA
SCHEMBL7956735 0.82 KCNJ1 (0.51) KCNJ1KCNH2DRD4ALDH1A1GAA
SCHEMBL6980061 0.81 KCNJ1 (0.47) KCNJ1KCNH2DRD4ALDH1A1GAA
SCHEMBL6983851 0.80 KCNJ1 (0.39) KCNJ1KCNH2ALDH1A1GAASMN1; SMN2
SCHEMBL6984463 0.77 POLB (0.44) ALDH1A1LMNAKDM4E
SCHEMBL6974890 0.74 DPP8 (0.37) KCNJ1KCNH2ALDH1A1SMN1; SMN2FFAR1
SCHEMBL24347338 0.71 HSD17B3 (0.45) ALDH1A1LMNAHPGD
SCHEMBL6985351 0.69 ALDH1A1 (0.54) ALDH1A1TP53
SCHEMBL6975443 0.68 TP53 (0.54) ALDH1A1GAASMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed